Amgen clotting drug gets FDA nod

Now it's time for the press release: The FDA approved Amgen's Nplate drug to treat a rare blood-clotting disorder that causes the body to attack its own platelets. Last month, Amgen mistakenly announced that Nplate had won the FDA nod, and had to retract the press release. This time, though, it's for real. Report

Suggested Articles

Mobile has become universal, accessible, and multi-generational. It’s time for life science brands to revolutionize how they’re telling their story.

Former Retrophin CEO was hoping for a SCOTUS hail mary to escape his seven-year fraud sentences Turns out the court was interest in hearing his plea.

A new investigation shines light on how Purdue pushed back on negative coverage of opioids, placed opioid-friendly experts in think tanks and more.